Skip to main content
Download PDF

Volume 6 Supplement 1

15<Superscript>th</Superscript>Paediatric Rheumatology European Society (PreS) Congress

  • Poster presentation
  • Open access
  • Published:

Rituximab is a therapeutical option for juvenile microscopic polyangiitis

Pediatric Rheumatology volume 6, Article number: P268 (2008) Cite this article

Introduction

Microscopic polyangitiis is characterized by anti-neutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis. The diseases usually respond to cyclophosphamide (Cyc) but some patients are therapy resistant. Rituximab (RIT) is a chimeric antibody to CD20 causing lysis of B-lymphocytes and used for treatment of lymphomas. RIT has also been successfully used in patients with rheumatoid arthritis (RA), idiopathic thromobocytopaenic purpura, autoimmune haemolytic anaemia, cold agglutinin disease, systemic lupus erythematosus and vasculitides.

Case report

A 16-year old female patient with hemoptysis, nephritis, dermatitis was diagnosed as a myeloperoxidase-ANCApositive microscopic polyangiitis. The patient was resistant to conventional therapy or had relapsed repeatedly after cessation of cyclophosphamide (Cyc). The patient was treated with intravenous infusions of rituximab (RIT).

Conclusion

RIT seems promising and safe in pediatric microscopic polyangiitis. Controlled studies should be conducted.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Innsbruck Medical University, Innsbruck, Austria

    J Brunner, M Prelog, E Binder, M Sailer-Höck, T Jungraithmayr & LB Zimmerhackl

  2. Department of Radiology, Innsbruck Medical University, Innsbruck, Austria

    M Freund

  3. Department of Nephrology, Innsbruck Medical University, Innsbruck, Austria

    G Mayer

Authors
  1. J Brunner
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. M Freund
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. M Prelog
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. E Binder
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. M Sailer-Höck
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. T Jungraithmayr
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. G Mayer
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. LB Zimmerhackl
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Brunner, J., Freund, M., Prelog, M. et al. Rituximab is a therapeutical option for juvenile microscopic polyangiitis. Pediatr Rheumatol 6 (Suppl 1), P268 (2008). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1546-0096-6-S1-P268

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1546-0096-6-S1-P268

Keywords

Pediatric Rheumatology

ISSN: 1546-0096